MANAGEMENT AND THERAPEUTIC OUTCOMES OF INFANTILE HEMANGIOMAS IN THE PERIOCULAR REGION: A REVIEW

Authors

DOI:

https://doi.org/10.31435/ijitss.4(52).2026.6869

Keywords:

Infantile Hemangioma, Periocular Region, Propranolol, Timolol, Ultrasound

Abstract

Background: Infantile hemangiomas (IHs) are benign vascular tumors of early childhood characterized by rapid postnatal proliferation followed by spontaneous involution. When localized to the periocular region, these lesions present substantial functional risks, including visual axis obstruction, astigmatism, and amblyopia.

Aim: The objective of this review is to evaluate the diagnostic dynamics, ultrasound characteristics, and therapeutic efficacy of topical and systemic beta-blocker therapies in managing periocular infantile hemangiomas.

Material and Methods: A comprehensive synthesis of clinical guidelines, consensus statements, and literature regarding periocular infantile hemangiomas, diagnostic imaging, and beta-blocker management protocols was conducted.

Results: Periocular hemangiomas frequently exhibit aggressive early volumetric growth, transitioning from ambiguous superficial lesions to large mixed tumors with robust vascular signals. While topical beta-blockers (such as timolol) are effective for thin superficial components, rapidly progressing mixed and deep lesions necessitate systemic propranolol therapy. Standard dosing regimens titrated to approximately 2 mg/kg/day consistently achieve profound tumor involution, prevent permanent visual impairment, and demonstrate favorable long-term safety profiles.

Conclusion: Early multidisciplinary evaluation, serial ultrasound monitoring, and prompt initiation of beta-blocker therapy are crucial for optimizing functional and aesthetic outcomes in children with periocular infantile hemangiomas.

References

Adams, L., & Ryan, E. (2022). Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019. Australasian Journal of Dermatology, 63(4), 473–478. https://doi.org/10.1111/ajd.13906

Al-Haddad, C., El Salloukh, N. A., & El Moussawi, Z. (2019). beta-blockers in the treatment of periocular infantile hemangioma. Current Opinion in Ophthalmology, 30(5), 319–325. https://doi.org/10.1097/ICU.0000000000000591

Baruch, S., Ben Amitai, D., & Friedland, R. (2024). Rebound growth of infantile hemangiomas after propranolol versus atenolol treatment: A retrospective study. Dermatology, 240(5–6), 879–884. https://doi.org/10.1159/000542001

Ghahvehchian, H., Kashkouli, M. B., Ghanbari, S., Karimi, N., Abdolalizadeh, P., & Abri Aghdam, K. (2024). Long-term results of oral propranolol treatment protocol for periocular infantile hemangioma: Should there be any contraindication? Ophthalmic Plastic & Reconstructive Surgery, 40(1), 61–69. https://doi.org/10.1097/IOP.0000000000002507

Ginguerra, M. A., Saito, O., Fernandes, J. B. V. D., Castro, D. S., & Matayoshi, S. (2018). Clinical and radiological evaluation of periocular infantile hemangioma treated with oral propranolol: A case series. American Journal of Ophthalmology, 185, 48–55. https://doi.org/10.1016/j.ajo.2017.10.021

Goldenberg, D. C., Vikkula, M., Penington, A., Blei, F., Kool, L. S., Wassef, M., Frieden, I. J., & ISSVA Vascular Anomalies Classification Group. (2025). Updated classification of vascular anomalies: A living document from the International Society for the Study of Vascular Anomalies Classification Group. Journal of Vascular Anomalies, 6(2), e113. https://doi.org/10.1097/JOVA.0000000000000113

Gong, C., Yue, X., Zhang, L., Zhao, X., & Shu, Q. (2025). Prevalence and risk factors associated with the recurrence of infantile hemangiomas after discontinuation of propranolol: A systematic review and meta-analysis. Journal of Clinical Medicine, 14(21), 7846. https://doi.org/10.3390/jcm14217846

Han, K., Wei, J., Zheng, H., Li, X., Zhang, A., Ma, Y., Meng, J., & Hu, Y. (2024). Efficacy and safety of oral propranolol or topical timolol for the treatment of superficial infantile hemangiomas. Journal of Craniofacial Surgery. Advance online publication. https://doi.org/10.1097/SCS.0000000000001001

Herlihy, E. P., Kelly, J. P., Sidbury, R., Perkins, J. A., & Weiss, A. H. (2016). Visual acuity and astigmatism in periocular infantile hemangiomas treated with oral beta-blocker versus intralesional corticosteroid injection. Journal of AAPOS, 20(1), 30–33. https://doi.org/10.1016/j.jaapos.2015.10.014

Hu, J., Pan, L., Kong, H., & Lou, J. (2026). A systematic review and meta-analysis of the efficacy and safety of propranolol versus other drugs in the treatment of infantile hemangioma. Journal of Cosmetic Dermatology, 25(2), e70750. https://doi.org/10.1111/jocd.70750

Ji, Y., Chen, S., Yang, K., Zhang, X., Zhou, J., Li, L., Xiang, B., Qiu, T., Dai, S., Jiang, X., Lu, G., Qiu, L., Kong, F., & Zhang, Y. (2021). Efficacy and safety of propranolol vs atenolol in infants with problematic infantile hemangiomas: A randomized clinical trial. JAMA Otolaryngology–Head & Neck Surgery, 147(7), 599–607. https://doi.org/10.1001/jamaoto.2021.0454

Krowchuk, D. P., Frieden, I. J., Mancini, A. J., Darrow, D. H., Blei, F., Greene, A. K., Annam, A., Baker, C. N., Frommelt, P. C., Hodak, A., Pate, B. M., Pelletier, J. L., Sandrock, D., Weinberg, S. T., Whelan, M. A., & Subcommittee on the Management of Infantile Hemangiomas. (2019). Clinical practice guideline for the management of infantile hemangiomas. Pediatrics, 143(1), e20183475. https://doi.org/10.1542/peds.2018-3475

Kutz, A. M., Aranibar, L., Lobos, N., & Wortsman, X. (2015). Color Doppler ultrasound follow-up of infantile hemangiomas and peripheral vascularity in patients treated with propranolol. Pediatric Dermatology, 32(4), 468–475. https://doi.org/10.1111/pde.12596

Kwon, E. K., Seefeldt, M., & Drolet, B. A. (2013). Infantile hemangiomas: An update. American Journal of Clinical Dermatology, 14(2), 111–123. https://doi.org/10.1007/s40257-013-0008-x

Léauté-Labrèze, C., Hoeger, P., Mazereeuw-Hautier, J., Guibaud, L., Baselga, E., Posiunas, G., Phillips, R. J., Caceres, H., Lopez Gutierrez, J. C., Ballona, R., Friedlander, S. F., Powell, J., Perek, D., Metz, B., Barbarot, S., Maruani, A., Szalai, Z. Z., Krol, A., Boccara, O., … Voisard, J. J. (2015). A randomized, controlled trial of oral propranolol in infantile hemangioma. New England Journal of Medicine, 372(8), 735–746. https://doi.org/10.1056/NEJMoa1404710

Lopez-Gutierrez, J. C. (2015). Current management of vascular tumors in the neonate. Current Pediatric Reviews, 11(3), 226–232. https://doi.org/10.2174/1573396311666150714105944

Macca, L., Altavilla, D., Di Bartolomeo, L., Irrera, N., Borgia, F., Li Pomi, F., Vaccaro, F., Squadrito, V., Squadrito, F., & Vaccaro, M. (2022). Update on treatment of infantile hemangiomas: What's new in the last five years? Frontiers in Pharmacology, 13, 879602. https://doi.org/10.3389/fphar.2022.879602

Malvindi, S., Sammarco, E., Elefante, A., Lanni, V., Cicala, D., Esposito, F., Picardi, C., Iuliano, A., Cohen, D., Mariniello, G., D'Aponte, A., Costagliola, C., Briganti, F., & Strianese, D. (2025). Real-life efficacy and safety of oral propranolol for ocular adnexal infantile hemangiomas: Observational cohort study. Frontiers in Ophthalmology, 5, 1493171. https://doi.org/10.3389/fopht.2025.1493171

Mazhar, A., Moosa, S., Abbas, A., Mallick, Y., & Samad, L. (2020). A multi-disciplinary, multimodal approach for the management of vascular anomalies. Pakistan Journal of Medical Sciences, 36(1), S14–S19. https://doi.org/10.12669/pjms.36.ICON-Suppl.1710

Qiao, J., Lin, J., Zhang, D., Li, J., Chen, C., Yu, H., Li, X., & Fang, B. (2020). Efficacy of combined topical timolol and oral propranolol for treating infantile hemangioma: A meta-analysis of randomized controlled trials. Frontiers in Pharmacology, 11, 554847. https://doi.org/10.3389/fphar.2020.554847

Samuelov, L., Kinori, M., Rychlik, K., Konanur, M., Chamlin, S. L., Rahmani, B., & Mancini, A. J. (2018). Risk factors for ocular complications in periocular infantile hemangiomas. Pediatric Dermatology, 35(4), 458–462. https://doi.org/10.1111/pde.13525

Shah, S. D., Baselga, E., McCuaig, C., Pope, E., Coulie, J., Boon, L. M., Garzon, M. C., Haggstrom, A. N., Adams, D., Drolet, B. A., Newell, B. D., Powell, J., García-Romero, M. T., Chute, C., Roe, E., Siegel, D. H., Grimes, B., & Frieden, I. J. (2016). Rebound growth of infantile hemangiomas after propranolol therapy. Pediatrics, 137(4), e20151754. https://doi.org/10.1542/peds.2015-1754

Smithson, S. L., Rademaker, M., Adams, S., Bade, S., Bekhor, P., Davidson, S., Dore, A., Drummond, C., Fischer, G., Gin, A., Grills, C., Halbert, A., Lokmic, Z., McCahon, E., Morgan, V. A., Murrell, D. F., Orchard, D., Penington, A., Purvis, D., … Phillips, R. (2017). Consensus statement for the treatment of infantile haemangiomas with propranolol. Australasian Journal of Dermatology, 58(2), 155–159. https://doi.org/10.1111/ajd.12600

Storch, C. H., & Hoeger, P. H. (2010). Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action. British Journal of Dermatology, 163(2), 269–274. https://doi.org/10.1111/j.1365-2133.2010.09848.x

Tran, A. Q., Choi, C. J., & Wester, S. T. (2016). Beta blockers in the treatment of periocular infantile hemangiomas: A review. Internal Medicine Review, 2(9), 221. https://doi.org/10.18103/imr.v2i9.221

Ye, X. X., Jin, Y. B., Lin, X. X., Ma, G., Chen, X. D., Qiu, Y. J., Chen, H., & Hu, X. J. (2012). [Topical timolol in the treatment of periocular superficial infantile hemangiomas: A prospective study]. Zhonghua Zheng Xing Wai Ke Za Zhi, 28(3), 161–164.

Zhao, J., Huang, A. H., Rainer, B. M., Kryatova, M. S., Eghrari, A. O., Wang, J., Puttgen, K. B., & Cohen, B. A. (2019). Periocular infantile hemangiomas: Characteristics, ocular sequelae, and outcomes. Pediatric Dermatology, 36(6), 830–834. https://doi.org/10.1111/pde.13925

Zhao, Z. F., Lü, R. R., Zhang, J., Huo, R., Xu, G. Q., Fu, H. B., Guo, X., Wui, J. C., & Lin, L. L. (2011). [Oral propranolol in the management of periorbital proliferating phase infantile hemangioma]. Zhonghua Zheng Xing Wai Ke Za Zhi, 27(3), 174–177.

Downloads

Published

2026-11-06

How to Cite

Shchebetun, D., Shchebetun, A., Trutsko, A. ., Abramchuk, O., Tetarchuk, V., Tetarchuk, V., & Tanko, A. . (2026). MANAGEMENT AND THERAPEUTIC OUTCOMES OF INFANTILE HEMANGIOMAS IN THE PERIOCULAR REGION: A REVIEW. International Journal of Innovative Technologies in Social Science, 1(4(52). https://doi.org/10.31435/ijitss.4(52).2026.6869